MYDA Advisors LLC Purchases Shares of 40,200 Billiontoone, Inc. $BLLN

MYDA Advisors LLC purchased a new stake in shares of Billiontoone, Inc. (NASDAQ:BLLN) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 40,200 shares of the company’s stock, valued at approximately $3,290,000.

Other hedge funds also recently bought and sold shares of the company. Baillie Gifford & Co. bought a new stake in Billiontoone during the fourth quarter valued at about $103,786,000. Massachusetts Financial Services Co. MA bought a new stake in Billiontoone during the fourth quarter valued at about $13,373,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Billiontoone during the fourth quarter valued at about $1,348,000. UBS Group AG bought a new stake in Billiontoone during the fourth quarter valued at about $2,586,000. Finally, Adams Street Partners LLC bought a new stake in Billiontoone during the fourth quarter valued at about $140,063,000.

Analyst Ratings Changes

A number of research firms have issued reports on BLLN. BTIG Research decreased their price target on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a report on Thursday, May 7th. JPMorgan Chase & Co. upped their price target on shares of Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Wall Street Zen upgraded shares of Billiontoone from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Wells Fargo & Company reduced their target price on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a research note on Thursday, March 5th. Finally, Guggenheim increased their target price on shares of Billiontoone from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Six research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Billiontoone presently has an average rating of “Moderate Buy” and an average price target of $125.29.

Billiontoone Price Performance

NASDAQ BLLN opened at $101.12 on Monday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.58 and a current ratio of 10.92. The firm has a 50-day simple moving average of $88.03 and a 200 day simple moving average of $87.97. Billiontoone, Inc. has a twelve month low of $61.96 and a twelve month high of $138.70. The stock has a market cap of $4.65 billion and a PE ratio of 183.85.

Billiontoone (NASDAQ:BLLN) last released its earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.33. The company had revenue of $108.39 million during the quarter, compared to the consensus estimate of $95.81 million. During the same quarter in the previous year, the business posted ($0.39) EPS. The firm’s quarterly revenue was up 83.8% on a year-over-year basis. On average, research analysts forecast that Billiontoone, Inc. will post 0.93 EPS for the current year.

Insider Activity at Billiontoone

In related news, insider Shan Riku Sakakibara sold 8,000 shares of the stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $98.22, for a total value of $785,760.00. Following the completion of the sale, the insider owned 212,000 shares in the company, valued at approximately $20,822,640. This trade represents a 3.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Oguzhan Atay sold 12,500 shares of the stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $98.22, for a total transaction of $1,227,750.00. Following the completion of the sale, the insider owned 187,500 shares of the company’s stock, valued at approximately $18,416,250. The trade was a 6.25% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 60,750 shares of company stock worth $5,979,598.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.